SCHEMBL8333360

SCHEMBL8333360

C1CCC(CCN2CCCC2)NC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CXCR4 P61073 1/20 0.42
CYP2D6 P10635 2/20 0.41
HTR1A P08908 2/20 0.41
HTR2A P28223 2/20 0.41
KCNH2 Q12809 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
MLNR O43193 1/20 0.41
ABCB11 O95342 1/20 0.41
EGFR P00533 1/20 0.41
FYN P06241 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2A P08913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961057 0.98 CYP1A2 (0.48) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL5683177 0.98 CYP1A2 (0.48) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL4454573 0.98 CYP1A2 (0.48) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL11300211 0.94 CXCR4 (0.44) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL27980795 0.88 CXCR4 (0.51) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL18183309 0.86 HTR1A (0.40) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL24322571 0.85 ACHE (0.43) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL9676237 0.85 CXCR4 (0.49) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL31058271 0.85 CYP1A2 (0.43) CYP1A2CXCR4CYP2D6HTR1AHTR2A
SCHEMBL24322374 0.85 ACHE (0.43) CYP1A2CXCR4CYP2D6HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925642-A ANTITUMOR, ANTIMETASTASIS AGENTS; DRUG RESISTANCE MODULATORS; SYNERGISTIC MIXTURES WITH ANTIBIOTICS AND CYTOSTATIC AGENTS; SIDE EFFECT REDUCTION BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1999-07-20 US disclosed
US-5668131-A CONTROLLING HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1997-09-16 US disclosed
US-5561140-A IMMUNOSUPPRESSANTS; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1996-10-01 US disclosed
US-5530119-A IMMUNOSUPPRESSANTS ABBOTT LABORATORIES (US) 1996-06-25 US disclosed
EP-0690713-A1 SUBSTITUTED ALICYCLIC AMINE-CONTAINING MACROCYCLIC IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1996-01-10 EP disclosed
WO-1994021254-A1 SUBSTITUTED ALICYCLIC AMINE-CONTAINING MACROCYCLIC IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1994-09-29 WO disclosed